Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHE/300003 stock hub

SHE/300003 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300003is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

26.7B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300003

In the news

Latest news · SHE/300003

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.9

P25 17.1P50 24.2P75 37.8

Trailing P/E32.2

P25 23.5P50 41.3P75 83.2

ROE4.9

P25 -0.9P50 4.1P75 8.8

ROIC5.2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300003 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

CNY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	8,689
Employees Change	-123%
Employees Change Percent	-1.4
Enterprise value	CNY 29.9B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Isin	CNE100000H44
Last refreshed	2026-05-10
Market cap	CNY 26.7B
Price	CNY 14.49
Price currency	CNY
Rev Per Employee	738,699.69x
Sector	Healthcare
Sic	3841
Symbol	she/300003
Website	https://www.lepumedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.11%
EV Earnings	36.02x
EV/EBIT	25.38x
EV/EBITDA	24.21x
EV/FCF	48.82x
EV/Sales	4.66x
FCF yield	2.29%
Forward P/E	21.88x
P/B ratio	1.49x
P/E ratio	32.17x
P/S ratio	4.16x
PE Ratio10 Y	40.28x
PE Ratio3 Y	52.26x
PE Ratio5 Y	40.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.36%
FCF margin	9.54%
Gross margin	61.75%
Gross Profit	CNY 4B
Gross Profit Growth	17.48%
Gross Profit Growth Q	-6.69%
Gross Profit Growth3 Y	-15.62%
Gross Profit Growth5 Y	-7.76%
Net Income	CNY 830.3M
Net Income Growth	478.16%
Net Income Growth Q	-34.8%
Net Income Growth Years	1%
Net Income Growth3 Y	-28.32%
Net Income Growth5 Y	-17.28%
Pretax Margin	15.74%
Profit Margin	12.94%
Profit Per Employee	CNY 95,555
Profitable Years	20
ROA	2.9
Roa5y	4.87
ROCE	5.43
ROE	4.92
Roe5y	9.2
ROIC	5.16
Roic5y	9.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.69%
Cagr15y	2.68%
Cagr1y	29.87%
Cagr3y	-13.19%
Cagr5y	-11.88%
Div CAGR10	15.58%
Div CAGR3	2.68%
Div CAGR5	8.28%
EPS Growth	478.7
EPS Growth Q	-34.78
EPS Growth Years	1
EPS Growth3 Y	-28.4
EPS Growth5 Y	-17.83
FCF Growth	67.42%
FCF Growth Q	-90.88%
FCF Growth3 Y	-22.58%
FCF Growth5 Y	-24.92%
OCF Growth	35.63%
OCF Growth Q	-34.4%
OCF Growth10 Y	10.44%
OCF Growth3 Y	-14.64%
OCF Growth5 Y	-16.01%
Revenue Growth	8.47x
Revenue Growth Q	-3.7x
Revenue Growth Years	1x
Revenue Growth3 Y	-15.12x
Revenue Growth5 Y	-6.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.25
Assets	CNY 25.6B
Cash	CNY 4B
Current Assets	CNY 9.2B
Current Liabilities	CNY 3.9B
Debt	CNY 5.7B
Debt EBITDA	CNY 4.57
Debt Equity	CNY 0.31
Debt FCF	CNY 9.22
Equity	CNY 18B
Interest Coverage	4.22
Liabilities	CNY 7.6B
Long Term Assets	CNY 16.4B
Long Term Liabilities	CNY 3.7B
Net Cash	CNY -1.7B
Net Cash By Market Cap	CNY -6.21
Net Debt Equity	CNY 0.09
Net Debt FCF	CNY 2.71
Tangible Book Value	CNY 10.8B
Tangible Book Value Per Share	CNY 5.85
WACC	5.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.38
Inventory Turnover	1.25
Net Working Capital	CNY 3.6B
Quick ratio	1.71
Working Capital	CNY 5.4B
Working Capital Turnover	CNY 1.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.1%
Dividend Growth	-37.11%
Dividend Growth Years	0%
Dividend per share	CNY 0.33
Dividend Years	16
Dividend Yield	2.25%
Last Dividend	CNY 0.16
Payout Ratio	94.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-6.69%
1Y total return	29.85%
200-day SMA	17.06
3Y total return	-34.6%
50-day SMA	16.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-46.85%
All Time High	46.96
All Time High Change	-69.14%
All Time High Date	2020-07-13
All Time Low	3.83
All Time Low Change	278.82%
All Time Low Date	2012-12-03
ATR	0.44
Beta	0.23
Beta1y	0.56
Beta2y	0.88
Ch YTD	-8.35
High	14.63
High52	21.6
High52 Date	2026-01-14
High52ch	-32.92%
Low	14.37
Low52	11.12
Low52 Date	2025-05-29
Low52ch	30.31%
Ma50ch	-11.97%
Price vs 200-day SMA	-15.06%
RSI	33.76
RSI Monthly	46.54
RSI Weekly	36.85
Sharpe ratio	0.75x
Sortino ratio	1.51
Total Return	2.34%
Tr YTD	-8.35
Tr15y	48.58%
Tr1m	-10.33%
Tr1w	0.35%
Tr3m	-18.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.2B
Operating Income Growth	292.6
Operating Income Growth Q	-16.72
Operating Income Growth3 Y	-24.56
Operating Income Growth5 Y	-13.88
Operating margin	18.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,131,696,634%
Net Borrowing	-302,041,566
Shares Insiders	13.02%
Shares Institutions	11.14%
Shares Out	1,843,424,716
Shares Qo Q	0.04%
Shares Yo Y	-0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 612.6M
Average Volume	26,256,158.6x
Bv Per Share	8.92
CAPEX	CNY -760.2M
Ch10y	-17.22
Ch15y	26.83
Ch1m	-10.33
Ch1w	0.35
Ch1y	27.33
Ch3m	-18.73
Ch3y	-39.12
Ch5y	-51.62
Ch6m	-13.44
Change	0.35%
Change From Open	0.35
Close	14.44
Days Gap	0
Depreciation Amortization	407,912,574
Dollar Volume	351,887,737.3
Earnings Date	2026-04-23
EBIT	CNY 1.2B
EPS	CNY 0.45
F Score	7
FCF	CNY 612.6M
FCF EV Yield	2.05x
FCF Per Share	CNY 0.33
Financing CF	-1,171,006,435
Fiscal Year End	December
Founded	1,999
Goodwill	3,619,848,802
Graham Number	9.94082
Graham Upside	-31.4
Income Tax	CNY 145M
Investing CF	-271,287,041
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2016-06-23
Last Split Type	Forward
Lynch Fair Value	CNY 2.25
Lynch Upside	-84.46
Ma150	17.05
Ma150ch	-15%
Ma20	15.58
Ma20ch	-7%
Net CF	-109,501,534
Next Earnings Date	2026-08-28
Open	14.44
P FCF Ratio	43.6
P OCF Ratio	19.46
Payment Date	2025-09-23
Position In Range	46.15
Ppne	4,116,906,075
Price Date	2026-05-08
Ptbv Ratio	2.48
Relative Volume	0.92x
Revenue	6,418,561,613x
Tax By Revenue	2.26x
Tax Rate	14.35%
Tr6m	-13.44%
Volume	24,284,868
Z Score	3.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300003 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$0.33 annual per share

Payout ratio

+94.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.3%

0 consecutive years of growth

Total shareholder yield

+2.3%

Dividend yield + buyback yield combined

Performance

SHE/300003 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300003?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.1%

Share of float held by funds and institutions

Insider ownership

+13.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

SHE/300003 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.8

Neutral momentum band

Price vs 200-day MA

-15.1%

50/200-day relationship not available

Beta (5Y)

0.23

Less volatile than the market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300003

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300003 stock rating?

she/300003 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300003 analysis?

The full report lives at /stocks/she/300003/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300003?

The latest report frames she/300003 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300003 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.